Literature DB >> 15643173

Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.

R E Sobel1, M D Sadar.   

Abstract

PURPOSE: This is part 2 of a 2-part review. Research into the molecular mechanisms underlying the various aspects of prostate cancer (PCa) requires the use of in vivo and in vitro model systems. In the last few years many new cell lines have been established by investigators from primary tissue sources and clonal derivatives of previously established lines. Therefore, the purpose of this 2-part review is to catalogue the current human cell lines developed for PCa research, as reported in the literature. Part 2 describes tissue culture cell lines derived by the insertion of transgenes, including human telomerase reverse transcriptase, SV40 T antigen and human papillomavirus genes. Part 2 also includes xenograft lines that require propagation and passage in vivo in mice.
MATERIALS AND METHODS: Prostate cell lines included in this review were identified by extensive searching of the literature using several strategies, including PubMed searches and book chapter reviews.
RESULTS: In total we describe the derivation, phenotype, genotype and characterization of molecular markers expressed by approximately 200 lines and sublines used in PCa research, including ones derived from primary tumors, metastases and normal prostate tissue. We paid particular attention to the expression of prostate specific antigen, androgen receptor, cytokeratins and other molecular markers used to indicate the status of PCa and the prostatic lineage of a given line. In an attempt to provide PCa researchers with a resource of information regarding new and established cell lines we have also created an online database of these PCa cell lines freely accessible via the World Wide Web at http://www.CaPCellLines.com. The web based interface allows researchers to peruse and print information regarding cell lines, add new cell lines and update or add new information regarding established cell lines.
CONCLUSIONS: This compendium of cell lines currently used in PCa research combined with access to our on-line database provides researchers with a continually updated and valuable resource for investigating the molecular mechanisms of PCa.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643173     DOI: 10.1097/01.ju.0000149989.01263.dc

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  53 in total

1.  Adrenal androgens rescue prostatic dihydrotestosterone production and growth of prostate cancer cells after castration.

Authors:  Yue Wu; Li Tang; Gissou Azabdaftari; Elena Pop; Gary J Smith
Journal:  Mol Cell Endocrinol       Date:  2019-02-23       Impact factor: 4.102

2.  Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line.

Authors:  Daniel C Lazar; Edward H Cho; Madelyn S Luttgen; Thomas J Metzner; Maria Loressa Uson; Melissa Torrey; Mitchell E Gross; Peter Kuhn
Journal:  Phys Biol       Date:  2012-02-03       Impact factor: 2.583

3.  Tissue slice grafts: an in vivo model of human prostate androgen signaling.

Authors:  Hongjuan Zhao; Rosalie Nolley; Zuxiong Chen; Donna M Peehl
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

4.  Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells.

Authors:  Johanny Tonos De Leon; Aki Iwai; Clementine Feau; Yenni Garcia; Heather A Balsiger; Cheryl L Storer; Raquel M Suro; Kristine M Garza; Sunmin Lee; Yeong Sang Kim; Yu Chen; Yang-Min Ning; Daniel L Riggs; Robert J Fletterick; R Kiplin Guy; Jane B Trepel; Leonard M Neckers; Marc B Cox
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

5.  Synthesis of dye conjugates to visualize the cancer cells using fluorescence microscopy.

Authors:  Yang Pu; Rui Tang; Jianpeng Xue; W B Wang; Baogang Xu; S Achilefu
Journal:  Appl Opt       Date:  2014-04-10       Impact factor: 1.980

6.  Identification of a LNCaP-specific binding peptide using phage display.

Authors:  Bin Qin; Wanyi Tai; Ravi S Shukla; Kun Cheng
Journal:  Pharm Res       Date:  2011-05-25       Impact factor: 4.200

7.  Handling and Assessment of Human Primary Prostate Organoid Culture.

Authors:  Tara McCray; Zachary Richards; Joseph Marsili; Gail S Prins; Larisa Nonn
Journal:  J Vis Exp       Date:  2019-01-17       Impact factor: 1.355

8.  Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.

Authors:  Michael A Augello; Craig J Burd; Ruth Birbe; Christopher McNair; Adam Ertel; Michael S Magee; Daniel E Frigo; Kari Wilder-Romans; Mark Shilkrut; Sumin Han; Danielle L Jernigan; Jeffry L Dean; Alessandro Fatatis; Donald P McDonnell; Tapio Visakorpi; Felix Y Feng; Karen E Knudsen
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

9.  Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.

Authors:  Teresa Chiaverotti; Suzana S Couto; Annemarie Donjacour; Jian-Hua Mao; Hiroki Nagase; Robert D Cardiff; Gerald R Cunha; Allan Balmain
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

10.  Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype.

Authors:  Matthias Saar; Hongjuan Zhao; Rosalie Nolley; Sarah R Young; Ilsa Coleman; Peter S Nelson; Robert L Vessella; Donna M Peehl
Journal:  Cancer Lett       Date:  2014-07-03       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.